Nervous System and Intracranial Tumour Incidence by Ethnicity in England, 2001–2007: A Descriptive Epidemiological Study

Background There is substantial variation in nervous system and intracranial tumour incidence worldwide. UK incidence data have limited utility because they group these diverse tumours together and do not provide data for individual ethnic groups within Blacks and South Asians. Our objective was to determine the incidence of individual tumour types for seven individual ethnic groups. Methods We used data from the National Cancer Intelligence Network on tumour site, age, sex and deprivation to identify 42,207 tumour cases. Self-reported ethnicity was obtained from the Hospital Episode Statistics database. We used mid-year population estimates from the Office for National Statistics. We analysed tumours by site using Poisson regression to estimate incidence rate ratios comparing non-White ethnicities to Whites after adjustment for sex, age and deprivation. Results Our study showed differences in tumour incidence by ethnicity for gliomas, meningiomas, pituitary tumours and cranial and paraspinal nerve tumours. Relative to Whites; South Asians, Blacks and Chinese have a lower incidence of gliomas (p<0.01), with respective incidence rate ratios of 0.68 (confidence interval: 0.60–0.77), 0.62 (0.52–0.73) and 0.58 (0.41–0.83). Blacks have a higher incidence of meningioma (p<0.01) with an incidence rate ratio of 1.29 (1.05–1.59) and there is heterogeneity in meningioma incidence between individual South Asian ethnicities. Blacks have a higher incidence of pituitary tumours relative to Whites (p<0.01) with an incidence rate ratio of 2.95 (2.37–3.67). There is heterogeneity in pituitary tumour incidence between individual South Asian ethnicities. Conclusions We present incidence data of individual tumour types for seven ethnic groups. Current understanding of the aetiology of these tumours cannot explain our results. These findings suggest avenues for further work.

[1]  A. Kyritsis,et al.  Descriptive Epidemiology of Cerebral Gliomas in Northwest Greece and Study of Potential Predisposing Factors, 2005–2007 , 2009, Neuroepidemiology.

[2]  A G Babiker,et al.  Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. , 1991, Statistics in medicine.

[3]  Cancer incidence in five continents. Volume VIII. , 2002, IARC scientific publications.

[4]  A functional polymorphism in XRCC1 is associated with glioma risk: evidence from a meta-analysis , 2012, Molecular Biology Reports.

[5]  E. Linos,et al.  Atopy and risk of brain tumors: a meta-analysis. , 2007, Journal of the National Cancer Institute.

[6]  H. Møller,et al.  Prostate cancer incidence, stage at diagnosis, treatment and survival in ethnic groups in South‐East England , 2010, BJU international.

[7]  Lei Wang,et al.  Risk association of meningiomas with MTHFR C677T and GSTs polymorphisms: a meta-analysis. , 2014, International journal of clinical and experimental medicine.

[8]  V. Beral,et al.  Cigarette smoking and risk of acoustic neuromas and pituitary tumours in the Million Women Study , 2010, British Journal of Cancer.

[9]  V. Beral,et al.  Incidence of gastrointestinal cancers by ethnic group in England, 2001–2007 , 2012, Gut.

[10]  M. Collins,et al.  McCune-Albright syndrome , 2008, Orphanet journal of rare diseases.

[11]  Z. Qi,et al.  Overweight, Obesity and Meningioma Risk: A Meta-Analysis , 2014, PloS one.

[12]  N. Rothman,et al.  DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma. , 2010, Neuro-oncology.

[13]  M. Plummer Improved estimates of floating absolute risk , 2004, Statistics in medicine.

[14]  J. Barnholtz-Sloan,et al.  The epidemiology of glioma in adults: a "state of the science" review. , 2014, Neuro-oncology.

[15]  P. Trott,et al.  International Classification of Diseases for Oncology , 1977 .

[16]  A. Sudo,et al.  Diffuse gliomas in an adolescent with multiple enchondromatosis (Ollier's disease). , 2010, Oncology letters.

[17]  C. Amos,et al.  Segregation analysis of cancer in families of glioma patients , 2001, Genetic epidemiology.

[18]  P. Brastianos,et al.  Turner syndrome and meningioma: support for a possible increased risk of neoplasia in Turner syndrome. , 2014, European journal of medical genetics.

[19]  J. Douwes,et al.  The global epidemiology of asthma in children. , 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[20]  Anssi Auvinen,et al.  Incidence of gliomas by anatomic location. , 2007, Neuro-oncology.

[21]  A. Sheikh,et al.  Ethnic variations in incidence of asthma episodes in England & Wales:national study of 502,482 patients in primary care , 2005, Respiratory research.

[22]  C. Dibben,et al.  The English indices of deprivation 2004 , 2011 .

[23]  M. Gatineau,et al.  Ethnicity and obesity in the UK , 2011, Perspectives in Public Health.

[24]  A. Ashworth,et al.  Determinants of age at menarche in the UK: analyses from the Breakthrough Generations Study , 2010, British Journal of Cancer.

[25]  H. Wichmann,et al.  Leveraging Ethnic Group Incidence Variation to Investigate Genetic Susceptibility to Glioma: A Novel Candidate SNP Approach , 2012, Front. Gene..

[26]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.

[27]  D. Parkin,et al.  Studies of cancer in migrants: rationale and methodology. , 1996, European journal of cancer.

[28]  D. Louis WHO classification of tumours of the central nervous system , 2007 .

[29]  Jamie Slowinski National Organization for Rare Disorders , 2014 .

[30]  Communities,et al.  English Indices of Deprivation , 2013 .

[31]  J. Stockman,et al.  Long-term Risks of Subsequent Primary Neoplasms Among Survivors of Childhood Cancer , 2013 .

[32]  Jacques Ferlay,et al.  GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet] , 2013 .

[33]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[34]  J. Kovi,et al.  Neoplasms of the central nervous system. Incidence and population selectivity in the Washington DC, metropolitan area , 1976, Cancer.

[35]  J. Butman,et al.  Neurofibromatosis type 2 , 2009, The Lancet.

[36]  J. Friedman Epidemiology of neurofibromatosis type 1. , 1999, American journal of medical genetics.

[37]  Thomas Harder,et al.  Birth weight and subsequent risk of childhood primary brain tumors: a meta-analysis. , 2008, American journal of epidemiology.

[38]  M. Little,et al.  Population-based risks of CNS tumors in survivors of childhood cancer: the British Childhood Cancer Survivor Study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  Juxiang Chen,et al.  Inverse association between eczema and meningioma: a meta-analysis , 2011, Cancer Causes & Control.

[40]  栗原 登,et al.  Trends cancer mortality for selected sites in 24 countries , 1960 .

[41]  R. Hay,et al.  London-born black Caribbean children are at increased risk of atopic dermatitis. , 1995, Journal of the American Academy of Dermatology.

[42]  Tarik Tihan,et al.  Brain tumor epidemiology: Consensus from the Brain Tumor Epidemiology Consortium , 2008, Cancer.

[43]  R. Thakker,et al.  Multiple endocrine neoplasia type 1. , 1999, Endocrine-related cancer.

[44]  A. Lophatananon,et al.  Comprehensive analysis of DNA repair gene variants and risk of meningioma. , 2008, Journal of the National Cancer Institute.

[45]  Z. Qi,et al.  Exogenous and Endogenous Hormones in Relation to Glioma in Women: A Meta-analysis of 11 Case-Control Studies , 2013, PloS one.

[46]  C. Mathers,et al.  GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer , 2013 .

[47]  H. Ren,et al.  Treating malignant glioma in Chinese patients: update on temozolomide , 2014, OncoTargets and therapy.

[48]  K. Pooley,et al.  Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis. , 2012, Journal of the National Cancer Institute.

[49]  C. Cobbs,et al.  Positive and Negative Associations of Human Leukocyte Antigen Variants with the Onset and Prognosis of Adult Glioblastoma Multiforme , 2005, Cancer Epidemiology Biomarkers & Prevention.

[50]  Paul Brennan,et al.  Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. , 2010, Journal of the National Cancer Institute.

[51]  L. Morgan,et al.  The epidemiology of glioma in adults: a "state of the science" review. , 2015, Neuro-oncology.

[52]  Yuri Quintana,et al.  Childhood cancer epidemiology in low‐income countries , 2008, Cancer.

[53]  D. Cook,et al.  Ethnic differences in use of hormone replacement therapy: community based survey , 1999, BMJ.

[54]  R. Barnard,et al.  The classification of tumours of the central nervous system. , 1982, Neuropathology and applied neurobiology.

[55]  Damien C Weber,et al.  Epidemiology of glial and non-glial brain tumours in Europe. , 2012, European journal of cancer.

[56]  S. Melmed,et al.  Pathophysiology of pituitary adenomas. , 2005, Journal of endocrinological investigation.

[57]  Joseph Wiemels,et al.  Epidemiology and etiology of meningioma , 2010, Journal of Neuro-Oncology.

[58]  J. Ross,et al.  Trends in childhood cancer incidence in the U.S. (1992–2004) , 2008, Cancer.

[59]  Y. Iwadate,et al.  Homozygous deletion of the p16/MTS-1/CDKN2 gene in malignant gliomas is infrequent among Japanese patients. , 1999, International journal of oncology.

[60]  D. Strachan,et al.  Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. , 1999, The Journal of allergy and clinical immunology.

[61]  G. Giles,et al.  Allergy and brain tumors in the INTERPHONE study: pooled results from Australia, Canada, France, Israel, and New Zealand , 2013, Cancer Causes & Control.

[62]  Robert N. Anderson,et al.  Annual Report to the Nation on the Status of Cancer, 1975–2007, Featuring Tumors of the Brain and Other Nervous System , 2011, Journal of the National Cancer Institute.

[63]  A. Schatzkin,et al.  Reproductive factors and exogenous hormone use and risk of adult glioma in women in the NIH‐AARP Diet and Health Study , 2011, International journal of cancer.

[64]  C. Stratakis,et al.  Genetics of Carney complex and related familial lentiginoses, and other multiple tumor syndromes. , 2000, Frontiers in bioscience : a journal and virtual library.

[65]  Z. Qi,et al.  Reproductive and Exogenous Hormone Factors in Relation to Risk of Meningioma in Women: A Meta-Analysis , 2013, PloS one.

[66]  M. Marmot,et al.  Why does birthweight vary among ethnic groups in the UK? Findings from the Millennium Cohort Study. , 2008, Journal of public health.

[67]  Hilla Peretz,et al.  Ju n 20 03 Schrödinger ’ s Cat : The rules of engagement , 2003 .

[68]  K. Aldape,et al.  ERCC1 and ERCC2 polymorphisms and adult glioma. , 2005, Neuro-oncology.

[69]  M. Hill Cancer Incidence in Five Continents, Volume VI , 1993 .

[70]  K. Aldape,et al.  Ethnicity delineates different genetic pathways in malignant glioma. , 2001, Cancer research.

[71]  R. Jenkins,et al.  Genetics of adult glioma. , 2012, Cancer genetics.

[72]  S. Ding,et al.  DNA repair gene ERCC1 polymorphisms may contribute to the risk of glioma , 2014, Tumor Biology.

[73]  A. Keyser,et al.  [Neurofibromatosis type 2]. , 1997, Nederlands tijdschrift voor geneeskunde.